Neimeth PLC earnings report shows N3.05 billion revenue jump year to date

Neimeth PLC is a pharmaceutical company that was bought out from Pfizer Inc in 1997.  The company distributes Pfizer products in Nigeria after it takes over Pfizer's business operation in Nigeria many years ago.

The company stock has struggled a lot over years, Neimeth stock is selling at N1.81 per share, and the stock is down -7 percent in one calendar year and down -18.8 percent year to date.

Check out the company's earning report below.

Neimeth International Pharmaceutical Plc released its unaudited financial results for the Q4 period ended 30th of September 2021.

• Revenue during the period was N3.05 billion. (+7.31% YoY)
• Cost of sales for the period was N1.60 billion (+20.08% YoY)
• Gross profit stood at N1.45 billion. (-3.94% YoY)
• Operating profit for the period was N412.83 million. (+4.98% YoY)
• Profit before tax of N247.37 million was recorded during the period.
• Profit for the period stood at N336.45 million (+58.35%)
• Total assets during the period stood at N6.33 billion. (-108.23mn YoY)
• Earnings per share of 17.72 kobo Vs 11.00 kobo YoY.

Click here to read more about Neimeth company stocks report.

As of now, we do not think it’s a good time to buy Neimeth shares.